Helpful Resources / Find a specialist

Find a specialist

The most important first step in defeating Merkel cell carcinoma is to build a team of MCC specialists.

Overview

Proper management of MCC almost always involves several of the following specialties: surgery, dermatology, radiation oncology and medical oncology. Established teams that are expert in the management of MCC exist at all of the centers listed below. Central contact persons from each institution are included in the listings.

Become a Verified MCC Specialist
United States
Arizona
Aleksandar Sekulic, MD, PhD
Mayo Clinic | Dept. of Dermatology
13400 E. Shea Blvd
Scottsdale, Arizona 85255
United States
James Warneke, MD
University of Arizona Cutaneous Oncology Program | Surgical Oncology
3838 N. Campbell Ave
Tucson, Arizona 85719
United States
Nathalie C. Zeitouni, MDCM. FRCPC, Mohs and Reconstructive Surgery
Medical Dermatology Specialists
1331 N 7th Street, Suite 250
Phoenix, Arizona 85006
United States
Arkansas
J. Camilo Barreto-Andrade, MD
University of Arkansas for Medical Sciences | Surgical Oncology
4018 W Capitol Ave
Little Rock, Arkansas 72205
United States
California
John B. Sunwoo, MD, FACS
Stanford University & VA Palo Alto | Head & Neck Surgery
875 Blake Wilbur Dr Rm 2223
Stanford, California 94305
United States
Kathryn Bollin, MD
Scripps MD Anderson | Hematology/Oncology
10666 North Torrey Pines Road
La Jolla, California 92037
United States
Kim Margolin, MD, Clinical Professor
City of Hope | Medical Oncology
1500 East Duarte Road
Duarte, California 91010
United States
Ling Gao, MD, PhD
UC Irvine Health | Department of Dermatology
118 Medical Surge 1
Irvine, California 92697
United States
Lisa Zaba MD, PhD
Stanford Cancer Center South Bay | Dept. of Dermatology
2589 Samaritan Drive
San Jose, California 95124
United States
Ralph Massey, MD
The Skin Cancer Group | Dept. of Mohs Micrographic & Dermatologic Surgery
1260 15TH STREET, #1401
Santa Monica, California 90404
United States
Seaver L. Soon, MD
Scripps Green Hospital
10666 N Torrey Pines Road, MS112A
La Jolla, California 92037
United States
Siegrid S. Yu, MD
University of California, San Francisco | Dermatologic Surgery (Mohs Micrographic Surgery and Cutaneous Oncology)
1701 Divisadero Street, 3rd Floor
San Francisco, California 94143
United States
Sunil A. Reddy, MD
Stanford Cancer Institute/Stanford Hospital | Medical Oncology
900 Blake Wilbur Dr, 3rd Floor
Stanford, California 94305
United States
Connecticut
Harriet Kluger, MD
Yale Cancer Center | Medical Oncology
35 Park St, 8th floor
New Haven, Connecticut 06520
United States
Florida
Amod A. Sarnaik, MD, FACS
H. Lee Moffitt Cancer Center and Research Institute | Surgical Oncology
10920 N. McKinley Dr.
Tampa, Florida 33612
United States
Andrew Brohl, MD
Moffitt Cancer Center | Medical Oncology
12902 Magnolia Drive
Tampa, Florida 33612
United States
Evan Wuthrick, MD
H. Lee Moffitt Cancer Center | Radiation Oncology
12902 Magnolia Drive
Tampa, Florida 33612
United States
Guilherme Rabinowits, MD
Miami Cancer Institute | Medical Oncology
8900 North Kendall Dr.
Miami, Florida 33176
United States
John Strasswimmer, MD, PhD
Boca Raton and Bethesda Hospitals: Baptist Health Cancer Institute
2605 West Atlantic Ave Suite D-204
Delray Beach, Florida 33445
United States
Jonathan Zager, MD, FACS
H. Lee Moffitt Cancer Center and Research Institute | Surgical Oncology
10920 N. McKinley Dr.
Tampa, Florida 33612
United States
Kenneth Y Tsai, MD, PhD
H. Lee Moffitt Cancer Center | Dermatology
10920 N. McKinley Dr
Tampa, Florida 33612
United States
Natalia Jaimes, MD
Sylvester Comprehensive Cancer Center / University of Miami Health System
1475 Northwest 12th Avenue, Floor 1
Miami, Florida 33136
United States
Vernon K. Sondak, MD
H. Lee Moffitt Cancer Center and Research Institute | Surgical Oncology
10920 N. McKinley Dr.
Tampa, Florida 33612
United States
Georgia
Ragini Kudchadkar, MD
Emory University Hospital | Medical Oncology
1365 Clifton Road NE Bldg Suite C2052
Atlanta, Georgia 30322
United States
Illinois
Ajay V. Maker, MD, FACS
Creticos Cancer Center at Advocate Illinois Masonic Medical Center & University of Illinois at Chicago | Surgical Oncology
900 W. Nelson St.
Chicago, Illinois 60657
United States
Jaehyuk Choi, MD PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Department of Dermatology
Chicago, Illinois 60611
United States
Sunandana Chandra, MD, MS
Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Medical Oncology
Chicago, Illinois 60611
United States
Maryland
Evan J. Lipson, MD
Johns Hopkins | Medical Oncology
201 N. Broadway
Baltimore, Maryland 21287
United States
Linda C Wang, MD, JD
Wang Dermatology | Medical & Surgical Dermatology
1205 York Road, Suite 39A
Lutherville, Maryland 21093
United States
Massachusetts
Ann W. Silk, MD, MS
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts 02215
United States
Charles H. Yoon, MD, PhD
Dana-Farber/Brigham and Women's Cancer Center| Surgical Oncology
450 Brookline Avenue
Boston, Massachusetts 02215
United States
Danielle N. Margalit, MD, MPH
Dana-Farber/Brigham and Women's Cancer Center| Radiation Oncology
450 Brookline Avenue
Boston, Massachusetts 02215
United States
David Miller, MD, PhD
Massachusetts General Hospital
55 Fruit Street
Boston, Massachusetts 02114
United States
Manisha Thakuria, MD
Dana-Farber/Brigham and Women's Cancer Center | Cutaneous Oncology
450 Brookline Avenue
Boston, Massachusetts 02215
United States
Reed E. Drews, MD
Beth Israel Deaconess Medical Center | Cutaneous Oncology Program
330 Brookline Avenue, Rabb 430
Boston, Massachusetts 02215
United States
Michigan
Kelly Harms, MD, PhD
Michigan Medicine | Cutaneous Surgery and Oncology
Rogel Cancer Center Floor 1, 1500 E. Medical Center Drive
Ann Arbor, Michigan 48109-5902
United States
Minnesota
Clark Clothier Otley, MD
Mayo Clinic | Division of Dermatologic Surgery
200 First Street SW
Rochester, Minnesota 55905
United States
James Jakub, MD
Mayo Clinic | Department of Surgery
200 First Street SW
Rochester, Minnesota 55905
United States
Missouri
Ryan Fields, MD, FACS
Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, Washington University School of Medicine | Surgical Oncology
Campus Box 8109
St. Louis, Missouri 63110
United States
New Jersey
Janice M. Mehnert, MD
Rutgers Cancer Institute of New Jersey | Medical Oncology
195 Little Albany Street
New Brunswick, New Jersey 08903
United States
New York
Daniel Coit MD, FACS
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, New York 10021
United States
Sherrif F. Ibrahim, MD, PhD
University of Rochester Wilmot Cancer Center | Division of Dermatologic Surgery
40 Celebration Dr
Rochester, New York 14620
United States
North Carolina
Nasreen A. Vohra, MD, FACS
Vidant Medical Center | Dept. of Surgery
600, Moye Blvd, Suite 4S-20
Greenville, North Carolina 27834
United States
Ohio
Brian Gastman, MD
Cleveland Clinic Foundation | Dermatology and Plastic Surgery Institute
9500 Euclid Ave, Desk A60
Cleveland, Ohio 44195
United States
Carlo Contreras, MD
The Ohio State Unviersity Comprehensive Cancer Center | Surgical Oncology
2050 Kenny Road
Columbus, Ohio 43221
United States
Jeremy Bordeaux, MD, MPH
UH Cleveland Medical Center | Department of Dermatology
11100 Euclid Avenue, Lakeside 3500
Cleveland, Ohio 44106
United States
Oregon
Thomas P. Trezona, MD, FACS
Sacred Heart Hospital Riverbend| Surgery
3783 International Ct
Springfield, Oregon 97477
United States
Pennsylvania
Clifford S. Perlis, MD, MBE
Keystone Dermatology Partners
216 Mall Boulevard, Suite 101
King of Prussia, Pennsylvania 19046
United States
Melissa Burgess, MD
University of Pittsburgh Medical Center Hillman Cancer Center | Medical Oncology
5115 Centre Avenue, Second Floor
Pittsburgh, Pennsylvania 15232
United States
Miriam Lango, MD
Fox Chase Cancer Center | Cutaneous Oncology Program
333 Cottman Avenue
Philadelphia, Pennsylvania 19111
United States
Texas
Dylan Lippert, MD
Baylor University Medical Center | Head and Neck Surgical Oncology & Reconstructive Surgery
411 N. Washington Ave, Suite 6400
Dallas, Texas 75246
United States
Frank Saporito, MD
Dallas Skin Cancer Center | Cutaneous Oncology | Dermatologic and Mohs Micrographic Surgery
411 N. Washington Ave, Suite 1200
Dallas, Texas 75246
United States
Mark D. Bonnen, M.D.
Baylor College of Medicine | Dan L. Duncan Comprehensive Cancer Center | Radiation Oncology
One Baylor Plaza, MS: BCM 711
Houston, Texas 77030
United States
Michael K Wong, MD, PhD, FRCPC
UT MD Anderson Cancer Center | Medical Oncology
1400 Holcombe Blvd.
Houston, Texas 77030
United States
Virginia
Sekwon Jang, MD
Inova Melanoma and Skin Cancer Center | Medical Oncology
8081 Innovation Park Dr
Fairfax, Virginia 22031
United States
Suraj Venna, MD
Inova Melanoma and Skin Cancer Center | Derm-Oncology
8081 Innovation Park Dr
Fairfax, Virginia 22031
United States
Washington
David Byrd, MD
Seattle Cancer Care Alliance | Skin Oncology Clinic
825 Eastlake Avenue East
Seattle, Washington 98195-8050
United States
Kelly Paulson, MD, PhD
Seattle Cancer Care Alliance | Cellular Immunotherapy
825 Eastlake Avenue North
Seattle, Washington 98109
United States
Paul Nghiem, MD, PhD
Seattle Cancer Care Alliance | Skin Oncology Clinic
825 Eastlake Avenue East
Seattle, Washington 98195-8050
United States
Shailender Bhatia, MD
Seattle Cancer Care Alliance | Skin Oncology Clinic
825 Eastlake Avenue East
Seattle, Washington 98195-8050
United States
Upendra Parvathaneni, MD
Univeristy of Washington Medical Center | Radiation Oncology
1959 NE Pacific St
Seattle, Washington 98105
United States
Wisconsin
Rohit Sharma, MD, FACS
Marshfield Clinic | Surgical Oncology
1000 North Oak Avenue
Marshfield, Wisconsin 54449
United States
Australia
Julie Howle, MD
Westmead Cancer Care Centre | Medical Oncology
Hawkesbury Road, Westmead, N.S.W
Sydney 2415
Australia
Professor Michael Veness, MD
Westmead Cancer Care Centre | Radiation Oncology
Hawkesbury Road, Westmead, N.S.W
Sydney 2415
Australia
Brazil
Milton Barros e Silva, MD
AC Camargo Cancer Center
1167, Pires da Mota St. Aclimação
São Paulo 01529-001
Brazil
Ronaldo Oliveira da Silva, MD
DermaOnco
Rua dos Andradas 1234/503
Porto Alegre 90020-008
Brazil
France
Astrid Blom, MD
CHU Ambroise Pare | Service de Dermatologie Generale et Oncologique
Email: astrid.blom@apr.aphp.fr
9 av Charles de Gaulle 92100 Boulogne-Billancourt
France
Germany
Juergen Becker MD, PhD
Essen University Hospital | Dermatology
Hufelandstrasse 55
Essen 45147
Germany
Stephan Grabbe, MD
University of Mainz Medical Center | Dept. of Dermatology
Langenbeckstr. 1
Mainz 55131
Germany
Thilo Gambichler, Prof. Dr. med.
St. Josef Hospital | Skin Cancer Center, Dept. of Dermatology, Ruhr-University Bochum
44791
Bochum
Germany
Greece
Alexander J. Stratigos, MD, PhD
Center for Melanoma Skin Cancer | Andreas Sygros Hospital for Skin and Venereal Diseases
5 Dragoumi Street
Athens 16121
Greece
Israel
Eyal Fenig, MD
Herzliya Medical Center | Department of Oncology
7 Ramat Yam St.
Herzliya 4685107
Israel
Japan
Kotaro Nagase, MD, PhD
Saga University Hospital | Department of Dermatology
5-1-1 Nabeshima
Saga 8498501
Japan
Netherlands
Alexander C.J. van Akkooi, MD, PhD
Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI-AVL) | Dept. of Surgical Oncology
Plesmanlaan 121, 1066 CX
Amsterdam
Netherlands
Marloes van Kester, MD, PhD
University Medical Center Groningen | Dept. of Dermatology
Hanzeplein 1
Groningen 9713 GZ
Netherlands
Norway
Åse Bratland, MD, PhD
Oslo University Hospital | Department of Oncology
Nydalen, 0424
Oslo
Norway
Poland
Piotr Rutkowski, MD, PhD
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology | Department of Soft Tissue/Bone Sarcoma and Melanoma
Roentgena Str. 5
Warsaw 02-781
Poland
Russia
Kristina Orlova, MD, PhD
N. N. Blokhin Russian Cancer Research Center | Medical Oncologist & Senior Clinical Researcher
24, Kashirskoye shosse,
Moscow 115478
Russia
Sweden
John Paoli, MD, Assoc. Prof
Sahlgrenska University Hospital
Department of Dermatology | Center for Skin Cancer and Surgery
Gothenburg 413 45
Sweden
Taiwan
Yi-Hua Liao, MD, PhD
National Taiwan University Hospital | Department of Dermatology
7, Chung-Shan South Rd
Taipei 10002
Taiwan
United Kingdom
Andrew Birnie, MD
Kent and Canterbury Hospital
Ethelbert Road
Canterbury CT1 3NG
United Kingdom
#8211
#8212
#8220
≤ 2 cm maximum tumor
1:30-2:30 pm et
1.7 cm in diameter
13th
13th congress
15%
2 cm maximum tumor
2 cm maximum tumor dimension
2 cm tumor dimension
2 nd primary
2 patients
2007
2009
2014
2015
2016
2017
2018
2018 dinner
2019
2019 1:30-2:30 pm
2019 1:30-2:30 pm et
2019 dinner
21 2016
400
60% of patients
6th annual
6th annual harley
6th annual harley haynes
6th annual harley haynes lectureship
8 th edition
8th edition
8th edition ajcc staging
8th edition ajcc staging system
8th edition staging
8th edition staging system
8th edition system
95%
95% ci
ability
abstract
academy
academy of dermatology
activate the patient's immune
activate the patient's immune system
activity
adam trial
adapted from agelli 2003
adapted from perrott 2003
adjuvant chemotherapy
adjuvant radiation therapy
advanced
advanced mcc
advice
agent gla-se for merkel
agent gla-se for merkel cell
aggressive
aggressive behavior
aggressive immunogenic
aggressive immunogenic cancer
ahronowitz u california san francisco
ajcc 8th
ajcc 8th edition
ajcc 8th edition system
ajcc staging manual 8th
ajcc staging manual 8th edition
ajcc staging system
akaike
al nejm 2016
alfred
alfred marchionini
allison
allison blankemeyer
alternative approaches
alternative therapies
american
american academy
american academy of dermatology
amerk serology test
amp
analyses
analytics
andrew schorr
annual
annual harley
annual harley haynes
annual harley haynes lectureship
anti-cd56 mab therapy for mcc
anti-tumor
anti-tumor immune
anti-tumor immune responses
antibodies cd8 t cells
antibody
antigen by yeast two-hybrid system
appearance of merkel cell
appearance of merkel cell carcinoma
approved
approved treatment
april
arkansas for medical sciences
article
asgari kaiser permanente northern california
assistant
athens
avelumab
award for innovative
award for innovative therapy
balzer cedars sinai los
balzer cedars sinai los angeles
basal cell
basal cell carcinoma
baseline
baseline imaging
becker amp
bed treatment after positive slnb
being studied by immune design
berlin
bhatia
bhatia spoke
bi
bianca lemos university of washington
bichakjian u michigan ann arbor
biology
biomarker
biomarker analyses
biomarker approach best predicts response
biopsy
blankemeyer
blood antibody levels
bob lutz kathy whiteman
bob lutz kathy whiteman immunogen
body
boise
bone muscle fascia or cartilage
bonnie balzer cedars sinai
bonnie balzer cedars sinai los
boston ma
breslow thickness
bringing
british
british columbia
brownell md phd
bump
byrd
california san francisco
california san francisco xrt
cam 5.2
cancer
cancer care
cancer care alliance
cancer cells
cancer center
cancer institute mcc
cancer institute mcc information
cancer therapy
cancers
carcinoma
carcinoma patients
carcinoma research
care
care alliance
carolyn messner dsw
carolyn messner dsw osw-c
carolyn messner dsw osw-c fapos
cases
cases/year
caused
cd8 t
cd8 t cells
cd8 t cells and prognosis
cedars sinai los angeles
cell
cell carcinoma
cell carcinoma patients
cell carcinoma quantity and quality
cell carcinoma research
cell epitopes from merkel polyomavirus
cell lines
cell lung cancer
cells
cells in the skin
cells that divide
center
center boston ma
center for reconstructive
center for reconstructive surgery
center new york
center new york ny
certain hormones
certifications
certifications and licenses
challenging
change in tumor size
characteristics
check to uw
checkpoint inhibitors
chemotherapy
chemotherapy drugs
chris bichakjian u michigan ann
chris bichakjian university of michigan
chronic lymphocytic
chronic lymphocytic leukemia
ci
citn-09/keynote-017 trial
click
click to view
clinic
clinical
clinical exam
clinical exam* no pathologic node
clinical photos page
clinical trial
clinical trial of adjuvant interferon
clinical trial of an immune
clinical trial's eligibility
clinical trial's eligibility requirements
clinical trials
clinical trials for mcc
clinical trials in mcc
clinical trials in mcc update
clinically
cll
closely by imaging scans
cm maximum tumor dimension
codes
codes for mcc
cohort
cohort b
cohort through jan
coley
colin
collaboration
collaboration with dr
colleagues
colleagues amp
collecting mcc patient outcomes data
columbia
common
company bristol-myers squibb
complementary alternative
completed
comprehensive cancer
comprehensive cancer center
confidence
confirmed via pathological exam
congress
consensus staging system
contact
contact information for the ordering
content
course
covid-19
critical
ct for merkel
ct for merkel the harvard
ct for merkel the mayo
ct scan
ctla-4 inhibitors
cycles
cytokeratin 20
dad
dana
data
database
decrease
degree
density
department
department of laboratory
department of laboratory medicine
department of laboratory medicine licenses
depending on the study
deputy director for skin/cutaneous
deputy director for skin/cutaneous oncology
dermatologist
dermatology
describe
description antibody against pd-1
developing mcc
development of mcc
diagnosis
diagram
dinner
director
director for skin/cutaneous
director for skin/cutaneous oncology
discussion
disease
disease recurrence
distant
distant metastasis
doctors
doses
download
draining lymph node
dsw osw-c fapos
dsw osw-c fapos faosw
due to a small sample
durable responses
duration of response
eado
edition ajcc staging system
edition staging system
editorial
educational
educational outreach
eligibility requirements
email
enroll in clinical
enroll in clinical trials
enrolled
enrolled in the seattle
entirely in selected mcc cases
epidermis
epitopes from merkel polyomavirus oncoproteins
eposter discussion
equal to 2 cm
equal to 2 cm maximum
erica shantha tarabadkar
erica shantha tarabadkar uw
established
et al
et al nejm
et al nejm 2016
eugene j
european
evan
event
evidence of disease
exam* no pathologic node exam
examples of mcc tumors
experience
expert
exploratory biomarker
exploratory biomarker analyses
exploring the role of hedgehog
exposure-response
exposure-response analyses
extensive sun exposure
facilitated discussion
familiar
family
family and friends
fccc philadelphia pa
feature a panel
feature a panel of experts
feedback
feedback email
felt on physical
felt on physical exam
fight
find
first line
fluid
flyer
focused
follow this link
followed closely by imaging
followed closely by imaging scans
followed over time
found
foundation
fred
fred hutch
fred hutchinson cancer research center
friedrich
friedrich merkel
friends
fruits and vegetables
fund
general health
generous
genetics of mcc
given intravenously
given intravenously or orally
gla-se for merkel cell
gla-se for merkel cell carcinoma
golf
grant
gregg
grief
group
guests
handout
hands
harley haynes
harley haynes lectureship
haynes lectureship
healthcare
healthcare provider
healthcare providers
heath
helen
helen leonard
help
higher risk of developing mcc
highlight
history of mcc
honor
hormones
hospital
hutch
hutchinson cancer research center
ibrahim u rochester
ibrahim u rochester ny
icd codes
identify the sentinel
identify the sentinel lymph
identify the sentinel lymph node
iiib patients with a known
il-12
illustrations
imaging
immune
immune checkpoint
immune checkpoint inhibitors
immune evasion
immune evasion mechanisms
immune responses
immune stimulating agent gla-se
immune stimulating therapy
immune suppressed
immune suppression
immune system
immune system to attack
immune therapy clinical
immune therapy clinical trials
immune-stimulating clinical trials for mcc
immunogenic
immunogenic cancer
immunotherapy
immunotherapy trials for mcc
improving
includes invading tumors
increase
india
information
initial
injectable in skin or possibly
injected at the site
innovative therapy
institution
interact with certain medications
interested
international
international symposium
interview
intravenously or orally
isaac brownell md
isaac brownell md phd
iyer j nghiem p
janet canning
japan
japanese
jayasri iyer u washington
jayasri iyer u washington seattle
jerry
jerry marsden university hospital birmingham
jerry wachter
jerry wachter fund
jim o'leary bob lutz kathy
johnston
join
joined
kaiser permanente northern california
kaplan-meier curves
kathy whiteman immunogen waltham ma
kawasumi
kelly harms university of michigan
keynote-555
kidney or heart transplantation
knew
know
lab
lab at uw
lab team
lab tours
laboratory
laboratory medicine
laboratory medicine licenses
laboratory medicine licenses and accreditations
layer
lecture
left
left to right
lemos
leonard
lesion
leukemia
liberty
liberty subaru
licenses
licenses and accreditations
life
limb
limb left
limb right
limb unspecified
line
list
local
local recurrence
locally advanced
location
long-term
look
lower limb
lutz kathy whiteman immunogen
lutz kathy whiteman immunogen waltham
lymph
lymph node
lymph node biopsy
lymph node dissection
lymph node dissection vs nodal
lymph node metastasis
lymph node region
lymph node(s
lymph nodes
lymphatic
lymphatic vessels
lymphocytic leukemia
lymphovascular invasion
madrid
malignant
manage
management
management of mcc
manual 8th edition
mapper mobile app project
mapper mobile app project possibilities
march 21
march 21 2016
marchionini
margin size
marsden university hospital birmingham uk
maryam asgari kaiser permanente northern
masaoki
masaoki kawasumi
mcc
mcc cohort
mcc cohort through jan
mcc differ in appearance
mcc management in ann arbor
mcc patient outcomes data getting
mcc patients
mcc patients from northern california
mcc research
mcc specialist
mcc specialists
mcc staging—new national data
mcc staging—new national data amp
mcc support
mcc support group
mcc tumor
mcc tumor cells
mcc tumors
mcc update on pembrolizumab anti-pd1
mcc-specific checklist for pathology features
mcc-specific survival
mccteam@uw.edu
mcpyv
mcpyv positive
mcpyv positive and negative
mcpyv positive and negative mcc
md phd
median
medical
medical advice
medical center
medical center boston ma
medical center new york
medical center new york ny
medical school
medicine
medicine licenses
medicine licenses and accreditations
meet the clinical
meet the clinical trial's eligibility
meeting
melanoma
members
members in merkel cell carcinoma
members of the nghiem
members of the nghiem lab
merkel
merkel cell
merkel cell carcinoma
merkel cell carcinoma patients
merkel cell carcinoma quantity
merkel cell carcinoma research
merkel cell carcinoma-specific t cells
merkel cell carcinomas
merkel cell polyomavirus
merkel cell polyomavirus-small t antigen
merkel cells
merkel dinner
merkel polyomavirus
merkel polyomavirus serology
merkel polyomavirus serology test
merkel the harvard experience amp
merkel the mayo experience amp
merkel virus serology
merkel virus serology test
messner dsw osw-c
messner dsw osw-c fapos
messner dsw osw-c fapos faosw
metastatic
metastatic mcc
mg/kg
michael
michael piepkorn
micrographic surgery
microsurgery
microvascular
milt
milton
milton r
milty
mmcc
modeling
mohs micrographic
mohs micrographic surgery
mohs surgery
mole mapper mobile app
mole mapper mobile app project
monica
mortality
multi-institutional trials of anti-cd56 mab
multi-modality mcc management in ann
multidisciplinary
multidisciplinary team
nat'l cancer institute
nat'l cancer institute mcc
nat'l cancer institute mcc information
natalie
national cancer institute
national comprehensive
national comprehensive cancer network®
negative by clinical exam
negative microscopic margins
neha singh
neligan
neoadjuvant
new tumor
new york ny
nghiem
nghiem et al
nghiem et al nejm
nghiem et al nejm 2016
nghiem lab
nghiem lab team
nghiem p
nghiem u washington seattle
nghiem's lab
nghiem's lab at uw
nghiem&#8217
node
node bed treatment after positive
node dissection vs nodal radiation
nodes
nodes negative by clinical
nodes negative by clinical exam
nodes negative by clinical exam*
nodes negative by pathologic exam
nodes positive by clinical
nodes positive by clinical exam
normal merkel
normal merkel cells
normal regulation
nutritional supplementation
nutritional supplementation program
o'leary bob lutz kathy
o'leary bob lutz kathy whiteman
older immune
older immune suppressed
oncologists
oncology
oncoprotein
oncoprotein antibodies
online
online contribution
online support
online support group
option for patients with metastatic
order to determine
organization
origin
orr
os
osterlof
osw-c fapos faosw
outcome compared to node-positive patients
outreach
overview
overview of current clinical trials
page to learn
palpable disease
palpable lymph
palpable lymph nodes
panel of experts
panel of experts including
participating in the adam
participating in the adam trial
participating in this trial
participation in the trial
parvathaneni
pathologic node exam performed
pathological exam
pathological exam performed
patient
patient handout
patient's immune system to attack
patients
patients treated
patients with a known primary
patients with advanced
patients with clinically
patients with cll
patients with mcc
patients with mcpyv negative tumors
patients with metastatic
patients with metastatic mcc
patients with mmcc
patients with recurrent
patients with recurrent locally
patients with recurrent locally advanced
patients with this cancer
patients without palpable
paul
paul nghiem
paul nghiem u washington
paul nghiem u washington seattle
paul nghiem university of washington
paul nghiem uw-seattle
paul nghiem uw-seattle amp
pay
pd-l1
pd1 and tim3 exhaustion markers
pembrolizumab
people
perrott 2003 with permission
personal
personal data
pet vs ct
pet vs ct for merkel
pet-cts in managing mcc
pharmaceutical company bristol-myers
pharmaceutical company bristol-myers squibb
pharmacokinetic
pharmacokinetic modeling
phase ii trial
phd
photos
photos of mmig members
physician
physician assistant
physician prior
physician prior to beginning
physicians
physicians determine
piepkorn
plan
planned 8th edition ajcc
planned 8th edition ajcc staging
planned gifts
planned gifts provide
planned giving
plastic surgery
polyomavirus
polyomavirus serology test
positive and negative
positive and negative mcc
positive and negative mcc cells
positive by clinical exam
positive slnb clnd vs
positive slnb clnd vs xrt
potential
present
presentation
presentations
presented
presented on the #8220
primary
primary site
primary tumor
primary tumor invades bone muscle
primary tumor site management amp
prior to beginning
prize
proceed
produce
produce certain hormones
produce oncoprotein antibodies
professional
prognosis
program as some supplements
progress
progress being
project data sphere
proper
proposed ajcc staging system
protein
provide
provider
published
queensland
questions
radiation
radiation entirely in selected mcc
radiation oncology
radiation therapy
radiation to the primary tumor
radiotherapy
randomized trial for adjuvant chemotherapy
rare
rate
ready
received
reconstruction
reconstructive
reconstructive microsurgery
reconstructive surgery
recurrence
recurrence free survival
recurrence risk
recurrence risk calculator
recurrence-free survival
recurrent locally
recurrent locally advanced
recurrent or metastatic lesions
region
regional
regional lymph node metastasis
regional lymph nodes
regional nodes
regional or distant
regional or distant metastasis
regulation
relevant
remission
research
research efforts
research scientist
resources page
response
response rate
responses
reviewed
revised mcc staging system
rick
right
risk
risk of developing
risk of developing mcc
risk of having a recurrence
risk of recurrence
robert royer
row
royer
s presentation
safety
samples
san francisco ca
scan
scott award
scott award for innovative
scott award for innovative therapy
scout skin cancer outcomes
seattle
seattle cancer care
seattle cancer care alliance
seattle mcc
seattle mcc support
seattle mcc support group
seattle translational
seattle translational tumor
seattle translational tumor research
see
sendai
sentinel
sentinel lymph
sentinel lymph node
sentinel lymph node biopsy
sentinel lymph node(s
september
serology
serology test
serology titer
serve
serve as the principal investigator
serve as touch
serve as touch cells
serves as the basis
sherrif ibrahim u
sherrif ibrahim u rochester
sherrif ibrahim u rochester ny
side effects
siegrid yu u of california
siegrid yu ucsf san francisco
significant
signs
signs and symptoms
signs and symptoms of cancer
simpson's dominance index
single
single fraction
sirna-based screening
site
site of origin
size
size tumor includes
size tumor includes invading
size tumor includes invading tumors
skin
skin cancer
skin cancer with clinical trials
skin cancers
skin or possibly lymph
skin or possibly lymph nodes
slnb clnd vs xrt
small cell lung
small cell lung cancer
small sample size
song park university of washington
southern california los angeles
specialist
specialists
spirit
spoke
spread
squamous cell
squamous cell carcinoma
stage
stage iia due
stage iiib patients
staging
staging manual 8th edition
staging system
staging system for the ajcc
staging—new national data amp
stimulating agent gla-se for merkel
story
studied by immune design
study
study keynote-555
study team
study treatment avelumab
subaru
suggestions
suggestions and feedback
suggestions and feedback email
sun-exposed skin
supplementation program
supplementation program as some supplements
support
support group
surgeon
surgery
surgical
surgical excision
surgical margin
surgical margin size
surgical oncology
surveillance
survival
survival in merkel cell
survival in merkel cell carcinoma
survival outcome compared to node-positive
suspicious lesion
symposium
symptoms
symptoms of cancer
system
system for the ajcc staging
t antigen by yeast two-hybrid
t cell
t cell epitopes from merkel
t cells
t cells in mcc amp
taking
tarbox
tax-deductible online
tax-deductible online contribution
team
test
therapy
therapy clinical trials in mcc
therapy for metastatic mcc
time
tissue
tissues
titer
titer decreases
titers of oncoprotein antibodies
together
tomography scan
tomoko
tomoko akaike
toronto
touch
touch cells
training
translational research
translational tumor
translational tumor research
treated
treating
treatment
treatment after positive slnb clnd
treatment recommendations
trial
trial of an immune stimulating
trial's eligibility requirements
trials
trials for mcc
trials of anti-cd56 mab therapy
trip
tumor
tumor affect survival in mcc
tumor cells
tumor includes invading
tumor includes invading tumors
tumor invades bone muscle fascia
tumor research
tumor samples
tumor viral status
tumor viral status predict drug
tumors
typically
u of california san francisco
u rochester ny
u washington seattle
uncle
uncle milty
univ california san francisco
univ california san francisco xrt
university
university medical
university medical center
university of arkansas for medical
university of birmingham uk
university of southern california
university of southern california los
university of washington
university school of medicine
unknown primary mcc
unknown primary mcc immunobiology
unspecified
update on mcc staging—new national
updated
upper limb
upstaged
useful for all mcc
useful for all mcc patients
uw
uw department
uw department of laboratory
uw department of laboratory medicine
uw medicine
van scott
van scott award
van scott award for innovative
vegetable intake
vessels to the sentinel
vessels to the sentinel lymph
video
videos
view
viral proteins
viral status
viral status predict drug response
virtual
virus
virus-negative
virus-negative cases
virus-negative mcc
visit
visit the clinical photos
visit the clinical photos page
visitors
vs ct for merkel
wachter
wachter fund
wash
wash your hands
washington
website
work
world
xrt monotherapy in most cases
xrt to primary tumor site
yolles
yu u of california san
zent
zoom